RiboX Therapeutics Announces First Patient Dosed in Phase I/IIa Clinical Trial of RXRG001, the First Circular RNA Therapy for the Treatment of Radiation-Induced Xerostomia and Hyposalivation
PRINCETON, N.J., March 10, 2025 /PRNewswire/ — RiboX Therapeutics Ltd. (RiboX), a pioneering…
March 10, 2025
China Telecom and Partners Innovate Together! 5G UAV Medical Delivery Network Wins Global Mobile Award
HONG KONG, March 10, 2025 /PRNewswire/ — On March 5, during the…
March 10, 2025
AIM Vaccine's Iteratively Upgraded Diploid Rabies Vaccine Approved for Clinical Trials, Showing Significantly Higher Efficacy than Marketed Diploid Rabies Vaccines
HONG KONG, March 10, 2025 /PRNewswire/ — AIM Vaccine Co., Ltd. (06660.HK),…
March 10, 2025
U.S. FDA approves Celltrion's OMLYCLO® (omalizumab-igec) as the first and only biosimilar with interchangeability designation referencing XOLAIR®
OMLYCLO® (omalizumab-igec) is the first and only omalizumab biosimilar approved by the…
March 10, 2025
Appian Unveils Latest Platform Release for Faster, More Powerful Data Fabric and AI Experience
SYDNEY, March 10, 2025 /PRNewswire/ — Appian (NASDAQ: APPN) today announced the…
March 10, 2025
HKA WELCOMES FORENSIC ACCOUNTING EXPERT JACQUELINE WOODS TO HKA IN AUSTRALIA
SYDNEY, March 10, 2025 /PRNewswire/ — HKA, a leading global consultancy in…
March 10, 2025
Aeroband Hits the Right Note at SXSW: The Best Smart Musical Instrument Brand Inspiring the Future of Music
Unleash the Rhythm of Inspiration at SXSW with Aeroband AUSTIN, Texas, March…
March 9, 2025
Global Times: Up Close: President Xi joins national political advisors in education discussion
BEIJING, March 9, 2025 /PRNewswire/ — Chinese President Xi Jinping, also general secretary…
